| |
| |
|
| Insider
Information: |
Reynolds Francis |
| Relationship: |
10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
9,045,920 |
|
|
Indirect Shares
|
23,488 |
|
|
| Direct
Value |
$3,602,809 |
|
|
|
Indirect Value
|
$9,355 |
|
|
| Total
Shares |
9,069,408 |
|
|
| Total
Value |
$3,612,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Invivo Therapeutics Holdings Cor... |
NVIV |
10% Owner |
2014-05-09 |
9,045,920 |
2014-05-09 |
23,488 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-05-30 |
4 |
AS |
$3.33 |
$14,153 |
D/D |
(4,250) |
13,217,270 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-05-31 |
4 |
AS |
$3.30 |
$14,025 |
D/D |
(4,250) |
13,213,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-03 |
4 |
AS |
$3.51 |
$14,918 |
D/D |
(4,250) |
13,208,770 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-04 |
4 |
AS |
$3.85 |
$16,363 |
D/D |
(4,250) |
13,204,520 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-05 |
4 |
AS |
$3.89 |
$16,533 |
D/D |
(4,250) |
13,200,270 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-06 |
4 |
AS |
$3.91 |
$16,618 |
D/D |
(4,250) |
13,196,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-07 |
4 |
AS |
$4.12 |
$17,510 |
D/D |
(4,250) |
13,191,770 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-10 |
4 |
AS |
$4.51 |
$19,168 |
D/D |
(4,250) |
13,187,520 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-11 |
4 |
AS |
$4.36 |
$18,530 |
D/D |
(4,250) |
13,183,270 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-12 |
4 |
AS |
$4.14 |
$17,595 |
D/D |
(4,250) |
13,179,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-13 |
4 |
AS |
$3.79 |
$45,480 |
D/D |
(12,000) |
13,167,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-14 |
4 |
AS |
$3.88 |
$46,560 |
D/D |
(12,000) |
13,155,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-17 |
4 |
AS |
$4.07 |
$48,840 |
D/D |
(12,000) |
13,143,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-18 |
4 |
AS |
$3.82 |
$45,840 |
D/D |
(12,000) |
13,131,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-19 |
4 |
AS |
$3.79 |
$45,480 |
D/D |
(12,000) |
13,119,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-20 |
4 |
AS |
$3.80 |
$45,600 |
D/D |
(12,000) |
13,107,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-21 |
4 |
AS |
$3.76 |
$45,120 |
D/D |
(12,000) |
13,095,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-24 |
4 |
AS |
$3.73 |
$44,760 |
D/D |
(12,000) |
13,083,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-25 |
4 |
AS |
$3.79 |
$45,480 |
D/D |
(12,000) |
13,071,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-06-26 |
4 |
AS |
$4.10 |
$49,200 |
D/D |
(12,000) |
13,059,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-01 |
4 |
AS |
$4.14 |
$49,680 |
D/D |
(12,000) |
13,023,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-02 |
4 |
AS |
$4.10 |
$49,200 |
D/D |
(12,000) |
13,011,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-03 |
4 |
AS |
$4.01 |
$48,120 |
D/D |
(12,000) |
12,999,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-05 |
4 |
AS |
$4.00 |
$48,000 |
D/D |
(12,000) |
12,987,020 |
0 |
- |
|
| NVIV |
Invivo Therapeutics Holdi... |
CEO, CFO |
• • • |
2013-07-08 |
4 |
AS |
$4.01 |
$48,120 |
D/D |
(12,000) |
12,975,020 |
0 |
- |
|
360 Records found
|
|
Page 6 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
